Read More Pharma Industry News Innovent Biologics begins phase 1 trial of IBI315 in solid malignancies Innovent Biologics and Beijing Hanmi Pharmaceutical, a subsidiary of Hanmi Pharmaceutical, said that the first patient has been… bypharmanewsdailyNovember 28, 2019
